Tatsuo Shimura

Prof. Tatsuo Shimura


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2016 in Biomedical Reports
Verified
Journal Article
Open access
PDF file
TSTatsuo Shimura
Tatsuo Shimura
MSMasahiko Shibata
Masahiko Shibata
KGKenji Gonda
Kenji Gonda
TNTakahiro Nakajima
Takahiro Nakajima
SCShun Chida
Shun Chida
STSeiichi Takenoshita
Seiichi Takenoshita
Galectin-3, a β-galactoside-binding lectin, exhibits pleiotropic biological functions and has a role as one of the immunological modulators. However, the associations between circulating galectin-3 and immunological, inflammatory and nutritional parameters have not yet been fully elucidated. The serum concentration of galectin-3 was examined in association with interleukin-10 (IL-10), IL-12 and IL17 production, lymphocyte stimulation, neutrophil/lymphocyte ratio (NLR), white blood cell count (WBC), C-reactive protein (CRP) and rapid turnover proteins, including retinol-binding protein (RBP), prealbumin (PA) and transferrin (TF) in 50 patients with untreated colorectal cancers. Significant increases (P<0.05) were observed in the serum galectin-3 levels in patients with untreated colorectal cancer (9.6±4.5 ng/ml) compared with the normal controls (3.2±1.6 ng/ml). Higher serum galectin-3 concentrations were observed in patients with colon cancer (11.5±4.4 ng/ml) compared to in patients with rectal cancer (8.0±4.0 ng/ml) (P=0.005). The levels of circulating galectin-3 inversely correlated with the production of IL-10 (r=−0.59, P<0.001), and IL-12 (r=−0.69, P<0.001). Galectin-3 concentration also inversely correlated with the lymphocyte stimulation assay stimulation index (r=−0.42, P=0.021). However, the level of serum galectin-3 correlated with IL-17 production (r=0.67, P<0.001). Serum galectin-3 levels exhibited significant correlations with NLR (r=0.41, P=0.009), WBC (r=0.32, P=0.035), and CRP (r=0.63, P<0.001), and statistically significant inverse correlations with RBP (r=−0.45, P=0.002), PA (r=−0.46, P=0.001) and TF (r=−0.72, P<0.001). Galectin-3 may be one of the key factors in the regulation of immunological, inflammatory and nutritional conditions.

1 July 2018 in Journal of Surgical Research
Verified
Journal Article
Closed access
TSTatsuo Shimura
Tatsuo Shimura
MSMasahiko Shibata
Masahiko Shibata
KGKenji Gonda
Kenji Gonda
HOHirokazu Okayama
Hirokazu Okayama
MSMotonobu Saito
Motonobu Saito
KKKoji Kono
Koji Kono

1 January 2018 in FUKUSHIMA JOURNAL OF MEDICAL SCIENCE
Verified
Journal Article
Closed access
PDF file
TSTatsuo Shimura
Tatsuo Shimura
MSMasahiko Shibata
Masahiko Shibata
KGKenji Gonda
Kenji Gonda
SHSuguru Hayase
Suguru Hayase
WSWataru Sakamoto
Wataru Sakamoto
KKKoji Kono
Koji Kono
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

15 March 1995 in Cancer
Verified
Journal Article
Open access
TSTatsuo Shimura
Tatsuo Shimura
MHMasao Hagihara
Masao Hagihara
KTKentaro Takebe
Kentaro Takebe
BMBatmunkh Munkhbat
Batmunkh Munkhbat
KOKyoji Ogoshi
Kyoji Ogoshi
KTKimiyoshi Tsuji
Kimiyoshi Tsuji
In NcoI restriction fragment length polymorphism analysis of tumor necrosis factor-beta (TNF-beta) gene, the frequency of 10.5-kb homozygote is low in patients with lung cancer and is associated with a better prognosis. These results should be examined in other malignancies. Using polymerase chain reaction, the authors performed NcoI restriction fragment length polymorphism analysis in 152 patients with gastric cancer, in 69 patients with benign gastric lesion, and in 141 healthy volunteers. In 3-year survival, the 10.5-kb homozygote showed a better prognosis (87.1%) than other alleles (5.5-kb homozygote, 52.5%; heterozygote, 79.1%), and there was a statistically significant difference between the 10.5-kb homozygote and the 5.5-kb homozygote. In 3-year survival for Stages III and IV, the 10.5-kb homozygote also showed a better prognosis (64.9%) than other alleles (5.5-kb homozygote, 16.7%; heterozygote, 41.4%). There were statistically significant differences (10.5-kb homozygote vs. 5.5-kb homozygote, P < 0.01; heterozygote vs. 5.5-kb homozygote, P < 0.05). There was a statistical difference between all patients and Stages III and IV (P < 0.05). The 10.5-kb homozygote of TNF-beta gene is associated with a prolonged survival in patients with gastric cancer, as has been shown in the patients with lung cancer.

8 June 2018 in Clinical Journal of Gastroenterology
Verified
Journal Article
Closed access
YMYuko Murakami
Yuko Murakami
TSTatsuo Shimura
Tatsuo Shimura
RORyo Okada
Ryo Okada
YKYasuhide Kofunato
Yasuhide Kofunato
TITeruhide Ishigame
Teruhide Ishigame
STSeiichi Takenoshita
Seiichi Takenoshita

13 March 2018 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
TSTatsuo Shimura
Tatsuo Shimura
MSMasahiko Shibata
Masahiko Shibata
YKYasuhide Kofunato
Yasuhide Kofunato
RORyo Okada
Ryo Okada
TITeruhide Ishigame
Teruhide Ishigame
SMShigeru Marubashi
Shigeru Marubashi